Aeras Global TB Vaccine Foundation Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aeras Global TB Vaccine Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013079
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aeras Global TB Vaccine Foundation Inc (Aeras) is a nonprofit biotechnology organization that develops tuberculosis (TB) vaccines. The organization provides TB vaccine candidates, preclinical candidates and vaccine candidates. It offers services such as portfolio management, preclinical research, conducts clinical trials, research and development and epidemiological studies, among others. Aeras has partnership with research organizations, public and private sectors, academic institutions, individuals, pharmaceutical and biotechnology companies, funders and policy makers. The organization receives funds from The Bill and Melinda Gates Foundation and European donor governments. It operates in the US, China and South Africa, among others. Aeras is headquartered in Rockville, Maryland, the US.

Aeras Global TB Vaccine Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
NIBIO and Aeras Enters into Co-Development Agreement with Create Vaccine for TB Vaccines 10
China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 13
Aeras Enters Into Co-Development Agreement With Tianjin CanSino For Tuberculosis Vaccine 14
Aeras Enters Into Co-Development Agreement With China National Biotech Group 15
Asset Transactions 16
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 16
Aeras Global TB Vaccine Foundation Inc – Key Competitors 17
Aeras Global TB Vaccine Foundation Inc – Key Employees 18
Aeras Global TB Vaccine Foundation Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Mar 01, 2016: Danilo Casimiro Joins Aeras as Chief Scientific Officer 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aeras Global TB Vaccine Foundation Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Aeras Global TB Vaccine Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NIBIO and Aeras Enters into Co-Development Agreement with Create Vaccine for TB Vaccines 10
China CDC Enters Into R&D Agreement With Aeras Global For TB Vaccine 11
Aeras Enters Into R&D Agreement With GlaxoSmithKline Vaccines To Develop Tuberculosis Vaccine 12
Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 13
Aeras Enters Into Co-Development Agreement With Tianjin CanSino For Tuberculosis Vaccine 14
Aeras Enters Into Co-Development Agreement With China National Biotech Group 15
IDT Biologika Acquires Biopharmaceutical Development Center from Aeras 16
Aeras Global TB Vaccine Foundation Inc, Key Competitors 17
Aeras Global TB Vaccine Foundation Inc, Key Employees 18
Aeras Global TB Vaccine Foundation Inc, Other Locations 19

★海外企業調査レポート[Aeras Global TB Vaccine Foundation Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RigNet Inc (RNET):石油・ガス:M&Aディール及び事業提携情報
    Summary RigNet Inc (RigNet) is a technology company that provides applications, customized communication services and cyber security solutions. Its managed services include remote communications and technology services for onshore and offshore drilling rigs, support vessels, production facilities, a …
  • Nano-Terra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nano-Terra Inc (Nano-Terra) is a clean technology company that develops and commercializes nano technology products. The company’s products include coating, advanced materials, organic and inorganic molecules, materials, polymers and UV water filtration system. It provides surface science, c …
  • Shikoku Electric Power Co Inc (9507):企業の財務・戦略的SWOT分析
    Shikoku Electric Power Co Inc (9507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報
    Summary JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner synd …
  • Petrel Resources Plc (PET):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that provides exploration and production of crude oil and natural gas across Iraq. The company provides areas of operations such as Luhais and Subba in Southern Iraq, Tano Basin in Ghana, Porcupine Basin in Ireland, and others …
  • ADNOC Distribution-石油・ガス分野:企業M&A・提携分析
    Summary ADNOC Distribution, a subsidiary of Abu Dhabi National Oil Company is an integrated energy company. The company carries out the marketing and distribution of petroleum products within the UAE and internationally. The markets and distributes lubes, fuel and gas. The company is also a distribu …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • Wausau Paper Corporation:企業の戦略・SWOT・財務情報
    Wausau Paper Corporation - Strategy, SWOT and Corporate Finance Report Summary Wausau Paper Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Moog Inc.:企業のM&A・事業提携・投資動向
    Moog Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moog Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Ortho-Clinical Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Ortho-Clinical Diagnostics Inc (OCD) a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive soluti …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CommonSpirit Health:企業の戦略的SWOT分析
    CommonSpirit Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • United BioSource Corp-製薬・医療分野:企業M&A・提携分析
    Summary United BioSource Corp (UBC), a subsidiary of Express Scripts Holding Company is a provider of pharmaceutical support services. The company offers medicines and medical products. Its services comprise clinical development and late stage research, risk management and pharmacovigilance, nursing …
  • Boralex Inc:企業の発電所・SWOT分析2018
    Boralex Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Mitsubishi Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Rostelecom:企業の戦略・SWOT・財務情報
    Rostelecom - Strategy, SWOT and Corporate Finance Report Summary Rostelecom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Amkor Technology Inc (AMKR):企業の財務・戦略的SWOT分析
    Amkor Technology Inc (AMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆